Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

iwMyeloma 2015 | Clinical utility of flow cytometry in multiple myeloma

Bruno Paiva • 11 Apr 2015
iwMyeloma 2015
Multiple Myeloma

At the Myeloma 2015 meeting, Dr Bruno Paiva (University of Navarra, Spain) discusses the utility of flow cytometry as a therapeutic tool to identify precursor cells and detect the presence or absence of minimal residue disease (MRD) in multiple myeloma.

Speaker: Bruno Paiva

More from Bruno Paiva

MRD assessment as an early endpoint of treatment efficacy in AML: a PETHEMA registry study
2:22
MRD assessment as an early endpoint of treatment efficacy in AML: a PETHEMA registry study
Bruno Paiva • 6 Dec 2025
Combined assessment of CTCs and MRD for dynamic risk assessment of patients with multiple myeloma
2:25
Combined assessment of CTCs and MRD for dynamic risk assessment of patients with multiple myeloma
Bruno Paiva • 6 Dec 2025
Comprehensive genomic characterization of CTCs in multiple myeloma
1:38
Comprehensive genomic characterization of CTCs in multiple myeloma
Bruno Paiva • 6 Dec 2025
What is the most effective method for detecting circulating tumor cells in multiple myeloma?
1:40
What is the most effective method for detecting circulating tumor cells in multiple myeloma?
Bruno Paiva • 18 Sep 2025

Related Videos

A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
3:11
A Phase II trial investigating IberKDd in R/R multiple myeloma: the ReKInDLE study
Bruno Paiva • 7 Dec 2025
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
4:04
Remote therapeutic monitoring reduces infection-related hospitalizations in hematologic cancers
Bruno Paiva • 15 Dec 2025
Motixafortide + G-CSF HSC mobilization in pts with myeloma following quadruplet induction therapy
1:40
Motixafortide + G-CSF HSC mobilization in pts with myeloma following quadruplet induction therapy
Bruno Paiva • 6 Dec 2025
WGS of cfDNA for assessment of MRD in high-risk smoldering multiple myeloma
2:13
WGS of cfDNA for assessment of MRD in high-risk smoldering multiple myeloma
Bruno Paiva • 8 Dec 2025
The content of VJHemOnc is intended for healthcare professionals